Adage Capital Management L.P. 13D/13G Filings for TScan Therapeutics, Inc. (TCRX)

Adage Capital Management L.P. 13D and 13G filings for TScan Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-12
09:07 am
Purchase
2025-06-3013GTScan Therapeutics, Inc.
TCRX
Adage Capital Management L.P.1,350,000
2.520%
1,350,000increase
(New Position)
Filing